Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2016 3
2017 1
2018 6
2019 10
2020 10
2021 2
2022 3
2023 0

Text availability

Article attribute

Article type

Publication date

Search Results

34 results

Results by year

Filters applied: . Clear all
Page 1
The therapy of idiopathic pulmonary fibrosis: what is next?
Somogyi V, Chaudhuri N, Torrisi SE, Kahn N, Müller V, Kreuter M. Somogyi V, et al. Among authors: torrisi se. Eur Respir Rev. 2019 Sep 4;28(153):190021. doi: 10.1183/16000617.0021-2019. Print 2019 Sep 30. Eur Respir Rev. 2019. PMID: 31484664 Free PMC article. Review.
Comorbidities of IPF: How do they impact on prognosis.
Torrisi SE, Vancheri A, Pavone M, Sambataro G, Palmucci S, Vancheri C. Torrisi SE, et al. Pulm Pharmacol Ther. 2018 Dec;53:6-11. doi: 10.1016/j.pupt.2018.09.003. Epub 2018 Sep 5. Pulm Pharmacol Ther. 2018. PMID: 30193867 Review.
When to start and when to stop antifibrotic therapies.
Torrisi SE, Pavone M, Vancheri A, Vancheri C. Torrisi SE, et al. Eur Respir Rev. 2017 Oct 3;26(145):170053. doi: 10.1183/16000617.0053-2017. Print 2017 Sep 30. Eur Respir Rev. 2017. PMID: 28974541 Free PMC article. Review.
What We Know About the Pathogenesis of Idiopathic Pulmonary Fibrosis.
Puglisi S, Torrisi SE, Giuliano R, Vindigni V, Vancheri C. Puglisi S, et al. Among authors: torrisi se. Semin Respir Crit Care Med. 2016 Jun;37(3):358-67. doi: 10.1055/s-0036-1580693. Epub 2016 May 27. Semin Respir Crit Care Med. 2016. PMID: 27231860 Review.
Comorbidities in unclassifiable interstitial lung disease.
Prior TS, Hyldgaard C, Torrisi SE, Kronborg-White S, Ganter C, Bendstrup E, Kreuter M. Prior TS, et al. Among authors: torrisi se. Respir Res. 2022 Mar 16;23(1):59. doi: 10.1186/s12931-022-01981-3. Respir Res. 2022. PMID: 35296320 Free PMC article.
HRCT Patterns of Drug-Induced Interstitial Lung Diseases: A Review.
Distefano G, Fanzone L, Palermo M, Tiralongo F, Cosentino S, Inì C, Galioto F, Vancheri A, Torrisi SE, Mauro LA, Foti PV, Vancheri C, Palmucci S, Basile A. Distefano G, et al. Among authors: torrisi se. Diagnostics (Basel). 2020 Apr 22;10(4):244. doi: 10.3390/diagnostics10040244. Diagnostics (Basel). 2020. PMID: 32331402 Free PMC article. Review.
ERS International Congress, Madrid, 2019: highlights from the Interstitial Lung Diseases Assembly.
Dupin C, Fernandes V, Hernandez-Gonzalez F, Torrisi SE, Alfaro TM, Kreuter M, Wijsenbeek MS, Renzoni EA, Bargagli E, Nunes H, Spagnolo P, Bonella F, Molina-Molina M, Antoniou K, Poletti V. Dupin C, et al. Among authors: torrisi se. ERJ Open Res. 2020 Oct 5;6(4):00143-2020. doi: 10.1183/23120541.00143-2020. eCollection 2020 Oct. ERJ Open Res. 2020. PMID: 33043043 Free PMC article. Review.
New perspectives on management of idiopathic pulmonary fibrosis.
Puglisi S, Torrisi SE, Vindigni V, Giuliano R, Palmucci S, Mulè M, Vancheri C. Puglisi S, et al. Among authors: torrisi se. Ther Adv Chronic Dis. 2016 Mar;7(2):108-20. doi: 10.1177/2040622315624276. Epub 2016 Feb 1. Ther Adv Chronic Dis. 2016. PMID: 26977280 Free PMC article. Review.
34 results